Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.02.2021 | Case report

Ledipasvir/sofosbuvir

Subarachnoid-haemorrhage, brain stem haemorrhage and development of drug resistance: 11 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mizokami M, et al. Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan. Journal of Viral Hepatitis 28: 129-141, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/jvh.13395 Mizokami M, et al. Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan. Journal of Viral Hepatitis 28: 129-141, No. 1, Jan 2021. Available from: URL: http://​doi.​org/​10.​1111/​jvh.​13395
Metadaten
Titel
Ledipasvir/sofosbuvir
Subarachnoid-haemorrhage, brain stem haemorrhage and development of drug resistance: 11 case reports
Publikationsdatum
01.02.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-91320-1

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Levetiracetam

Case report

Multiple drugs

Case report

Lithium

Case report

Multiple drugs

Case report

Prednisolone